In vitro growth of multidrug-resistant Neisseria gonorrhoeae isolates is inhibited by ETX0914, a novel spiropyrimidinetrione ☆

Papp, John R.; Lawrence, Kenneth; Sharpe, Samera; Mueller, John; Kirkcaldy, Robert D.

doi:10.1016/j.ijantimicag.2016.05.018

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.

i

In vitro growth of multidrug-resistant Neisseria gonorrhoeae isolates is inhibited by ETX0914, a novel spiropyrimidinetrione ☆

Jul 12 2016
By Papp, John R. ; Lawrence, Kenneth ; Sharpe, Samera ; ...
http://dx.doi.org/10.1016/j.ijantimicag.2016.05.018
Source: Int J Antimicrob Agents. 48(3):328-330.

[PDF-301.91 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

Int J Antimicrob Agents
Personal Author:

Papp, John R. ; Lawrence, Kenneth ; Sharpe, Samera ; Mueller, John ; Kirkcaldy, Robert D.

Papp, John R. ; Lawrence, Kenneth ; Sharpe, Samera ; Mueller, John ; Kirkcaldy, Robert D. Less -
Description:

Antimicrobial resistance in Neisseria gonorrhoeae has severely limited the number of treatment options, and the emergence of extended-spectrum cephalosporin resistance threatens the effectiveness of the last remaining recommended treatment regimen. This study assessed the in vitro susceptibility of N. gonorrhoeae to ETX0914, a novel spiropyrimidinetrione that inhibits DNA biosynthesis. In vitro activity was determined by agar dilution against 100 N. gonorrhoeae isolates collected from men presenting with urethritis in the USA during 2012-2013 through the Gonococcal Isolate Surveillance Project. The minimum inhibitory concentration (MIC) that inhibited growth in 50% (MIC50) and 90% (MIC90) of isolates was calculated for each antimicrobial agent. ETX0914 demonstrated a high level of antimicrobial activity against N. gonorrhoeae, including isolates with decreased susceptibility or resistance to currently available agents. The ability of ETX0914 to inhibit the growth of N. gonorrhoeae was similar to ceftriaxone, which is currently recommended in combination with azithromycin to treat gonorrhoea. The data presented in this study strongly suggest that ETX0914 should be evaluated in a clinical trial for the treatment of N. gonorrhoeae.
Subjects:

[+]

Anti-Bacterial Agents Barbiturates Drug Resistance, Multiple, Bacterial Gonorrhea Humans Male Microbial Sensitivity Tests Spiro Compounds Urethritis
Source:

Int J Antimicrob Agents. 48(3):328-330.
Pubmed ID:

27499432
Pubmed Central ID:

PMC6198316
Document Type:

Journal Article
Funding:

CC999999/Intramural CDC HHS/United States
Place as Subject:

United States
Volume:

48
Issue:

3
Collection(s):

CDC Public Access
Main Document Checksum:

[+]

urn:sha256:f6136be3eb2cdb2b531227d5dacb787051293716d3b823881b647b1de0fae66b
Download URL:

https://stacks.cdc.gov/view/cdc/60034/cdc_60034_DS1.pdf
File Type:

nihms-992504.nxml

xml

More +